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Background Most diarrhoeal deaths can be prevented through the prevention
and treatment of dehydration. Oral rehydration solution (ORS)
and recommended home fluids (RHFs) have been recommended
since 1970s and 1980s to prevent and treat diarrhoeal dehydration.
We sought to estimate the effects of these interventions on diar-
rhoea mortality in children aged <5 years.
Methods We conducted a systematic review to identify studies evaluating the
efficacy and effectiveness of ORS and RHFs and abstracted study
characteristics and outcome measures into standardized tables. We
categorized the evidence by intervention and outcome, conducted
meta-analyses for all outcomes with two or more data points and
graded the quality of the evidence supporting each outcome. The
CHERG Rules for Evidence Review were used to estimate the effec-
tiveness of ORS and RHFs against diarrhoea mortality.
Results We identified 205 papers for abstraction, of which 157 were
included in the meta-analyses of ORS outcomes and 12 were
included in the meta-analyses of RHF outcomes. We estimated
that ORS may prevent 93% of diarrhoea deaths.
Conclusions ORS is effective against diarrhoea mortality in home, community
and facility settings; however, there is insufficient evidence to esti-
mate the effectiveness of RHFs against diarrhoea mortality.
Keywords Oral rehydration solution, oral rehydration therapy, recommended
home fluids, diarrhoea, child, systematic review, meta-analysis
Background
Diarrhoeal diseases are a leading cause of mortality
in children aged <5 years, accounting for 1.7 million
deaths annually.
1 Because the immediate cause of
death in most cases is dehydration, these deaths are
almost entirely preventable if dehydration is pre-
vented or treated. Until 1970s, intravenous (IV) infu-
sion of fluids and electrolytes was the treatment of
choice for diarrhoeal dehydration, but was expensive
and impractical to use in low-resource settings.
In 1960s and 1970s, physicians working in South
Asia developed a simple oral rehydration solution
(ORS) containing glucose and electrolytes that could
be used to prevent and treat dehydration due to diar-
rhoea of any aetiology and in patients of all ages.
2–8
At the time ORS was developed, placebo-controlled
trials would have been unethical given the efficacy of
IV therapy, and to our knowledge none exists. The
randomized controlled trials (RCTs) of ORS conducted
to confirm its efficacy instead used a comparator such
as IV therapy or alternative formulations of ORS.
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i75Similarly, studies conducted in community settings
to assess the effectiveness of ORS did not actively
withhold ORS from the comparison area but instead
evaluated the effectiveness of promotional campaigns
or alternative delivery systems compared with routine
health system delivery.
In 1970s, the World Health Organization (WHO)
recommended that an ORS formulation with total
osmolarity 311mmol/l be used for prevention and
treatment of diarrhoeal dehydration. However, alter-
native formulations continued to be investigated in
an attempt to develop an ORS formulation that
would decrease stool output or have other clinical
benefits. These efforts led, in 2004, WHO to recom-
mend low osmolarity ORS (with total osmolarity of
245mmol/l and reduced levels of glucose and
sodium), which was associated with reduced need
for unscheduled IV therapy, decreased stool output
and less vomiting when compared with the original
formulation.
9,10
As countries launched diarrhoeal disease control
programmes to roll out ORS, they faced difficulties
in ensuring access and achieving high coverage
levels, in part due to inadequate manufacturing
capacity. In an effort to improve provision of fluids
in early diarrhoea episodes to prevent the develop-
ment of dehydration, diarrhoeal disease control
programmes promoted the use of additional fluids
and home-made solutions such as rice water and
sugar salt solution [collectively referred to as recom-
mended home fluids (RHFs)].
11,12 RHFs were eventu-
ally incorporated into the WHO recommendations for
prevention of dehydration. Unfortunately, over the
years, programmes have combined ORS and RHFs
into a general and poorly defined oral rehydration
therapy (ORT) category in which the respective roles
of ORS and RHFs are not well delineated.
Recent Cochrane reviews have estimated the efficacy
of ORS compared with IV therapy, and reduced osmo-
larity ORS compared with original ORS, against treat-
ment failure.
10,13 Additionally, in 1998, a Cochrane
review examined the effect of rice-based, compared
with glucose-based, ORS on stool output and duration
of diarrhea.
14 However, these reviews focused on
RCTs of ORS conducted in hospitals or clinical settings
and did not examine mortality as an outcome or the
broader category of RHFs as an intervention. To our
knowledge, there are no systematic reviews or corre-
sponding meta-analyses assessing the effect of ORS or
RHFs on diarrhoea-specific mortality. We present
evidence from systematic reviews and meta-analyses
drawing upon data from community- and
facility-based studies to estimate the effectiveness of
ORS, and, separately, RHFs on diarrhoea morbidity
and mortality in children aged <5 years. We then cor-
relate the effectiveness estimates with achieved cover-
age levels to generate an estimate of the effect of each
intervention on cause-specific mortality.
Methods
Per CHERG Guidelines, we systematically reviewed
published literature from PubMed, the Cochrane
Libraries, and the WHO Regional Databases to identify
studies examining the effect of oral rehydration strate-
gies on diarrhoea morbidity and mortality in children
aged <5 years. Search terms included combinations
of diarrhea, dysentery, rotavirus, fluid therapy, oral rehydra-
tion solution, oral rehydration therapy, recommended home
fluid and sugar salt solution. We limited the search to
studies that included children aged <5 years and
studies in English, French, Spanish, Portuguese and
Italian.
Inclusion/exclusion criteria and definitions
For the purposes of this review, we defined and
reviewed three categories of oral rehydration strategies:
ORS, RHFs and ORT. We defined ORS as an electrolyte
solution containing sodium, chloride, potassium, bicar-
bonateorcitrateand glucoseoranotherformofsugaror
starch. Formulationscontainingsmallamountsofother
minerals, such as magnesium, were included in this
category, but solutions containing amino acids such as
glycine or alanine were excluded. We also excluded
solutions containing zinc, because it was not possible
to separate the effects of ORS and zinc on diarrhoea
morbidity. Both reduced osmolarity ORS (total osmo-
larity 4250 mmol/l, per Hahn
10) and higher osmolarity
ORS (up to 370 mmol/l) were included in our review.
For RHFs, we included all possible home fluid alter-
natives in our review, including sugar–salt solution,
cereal–salt solution, rice–water solution and additional
fluids such as plain water, juice, tea or rice water. If the
study intervention was promotion or provision of both
ORS and RHF in the same area and the effects and cov-
erage estimates of the two interventions could not be
separated, we categorized it as ORT. Such studies were
generally large-scale programme evaluations.
We included quasi-experimental, pre/post, observa-
tional and randomized and cluster-randomized trials
reporting any of the following outcomes for children
aged <5 years: all-cause or diarrhoea-specific mortal-
ity, diarrhoea hospitalizations, referrals to hospitals or
health centres for diarrhoea treatment, or treatment
failure. Studies in developed countries were excluded
unless conducted in a low-resource setting, such as
native American reservations. Treatment failure was
generally defined as the need for unscheduled IV
therapy, but we accepted other definitions provided
that they reflected failure of the therapy to produce
or maintain clinical improvement in the subjects’
dehydration state. Studies that defined treatment fail-
ure in terms of stool volume or duration of diarrhoea
were excluded.
Abstraction
We abstracted all studies meeting our acceptance cri-
teria into standardized tables, categorized by outcome,
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Abstracted variables included study identifiers and
context, design and limitations, population, character-
istics of the intervention and control and outcome
measures. Based on these data, we graded each
study according to the CHERG adaptation of the
GRADE technique.
15 Scores were decreased by half a
grade for each design limitation; observational stu-
dies, including pre/post studies, received a very low
grade.
Analysis
We summarized the evidence for ORS and RHFs by
outcome in a separate table and graded the quality of
evidence for each outcome, decreasing the score for
observational study designs, heterogeneity of study
outcomes or lack of generalizability of the study pop-
ulations or interventions. We did not produce a sum-
mary table for ORT because our goal was to generate
estimates of the individual rather than joint effective-
ness of ORS and RHFs, as each has different roles in
diarrhoea management. For each outcome with more
than one study, we conducted both fixed and random
effects meta-analyses.
Mortality
For diarrhoea-specific mortality, we included rando-
mized, cluster-randomized and quasi-experimental
studies in the meta-analysis. Observational studies
(other than quasi-experimental studies) that did not
control for confounding were excluded, as were case–
control studies and those that did not provide an ade-
quate estimate of coverage in the intervention arm.
We defined coverage as the proportion of diarrhoea
episodes in children aged <5 years for which the
child received ORS or RHFs. We excluded studies in
which a comparator or alternative delivery system was
used in the comparison arm, because the resulting
relative risk did not provide meaningful information
on the effect of ORS or RHFs on diarrhoea morbidity
or mortality. For ORS and, separately, RHFs, we
reported the pooled relative reduction in diarrhoea-
specific mortality and 95% confidence interval (CI).
In the case of heterogeneity, we reported the
DerSimonian–Laird pooled relative reduction and
95% CI.
Treatment failure
Observational studies and RCTs of ORS or RHFs
assessing treatment failure, including those that
used a comparator, were included in the meta-
analysis. For included studies, instead of a relative
risk, we analysed the absolute treatment failure rate
for each therapy that met our inclusion criteria. We
conducted separate and combined meta-analyses for
RCTs and observational studies and reported the
Mantel–Haenszel pooled failure rate and 95% CI, or
the DerSimonian–Laird pooled failure rate and 95% CI
if there was evidence of heterogeneity for each.
Hospitalization/referral
The clinical guidelines and processes for hospitaliza-
tion and referral in the studies we identified were
variables and often not well described. Moreover,
this outcome can be confounded by differences in
care-seeking or referral practices between study
arms, particularly in quasi-experimental studies, and
the studies included in our review did not adequately
address or adjust for this possibility. Given these con-
siderations, a meta-analysis was not appropriate for
this outcome, and none was conducted.
Overall effectiveness estimate
Applying the CHERG Rules for Evidence Review,
15 for
each outcome, we considered the quality of the evi-
dence, number of events and generalizability of the
study population and outcome to diarrhoea-specific
mortality to estimate the effects of ORS and RHFs
on diarrhoea mortality in children aged <5 years.
Results
Our searches identified 2397 titles; after screening
titles and abstracts, we reviewed 404 papers for our
inclusion/exclusion criteria and outcomes of interest
(Figure 1). We abstracted 205 papers into our final
database: 184 reporting data on ORS, 23 on RHFs
and 18 on ORT as defined above. For the outcomes
of diarrhoea and all-cause mortality, we excluded
many papers in our final database from the meta-
analysis because they used observational study
designs and did not control for confounding, did not
report an adequate coverage indicator, had no relevant
comparison group or used a case–control design. These
studies are shown in Supplementary tables 1 and 2,
but were not included in the meta-analyses or
summary tables (Supplementary tables 1 and 2).
ORS
We identified 21 papers reporting diarrhoea-specific
mortality, 3 reporting all-cause mortality, 20 reporting
hospitalization/referral and 155 reporting treatment
failure that met our inclusion/exclusion criteria
(Supplementary table 1). Of these, three papers
reporting diarrhoea mortality and 153 reporting treat-
ment failure were included in the meta-analyses.
Table 1 presents the summary characteristics of
these studies and meta-analysis results by outcome.
For the outcomes of diarrhoea mortality and treat-
ment failure, there was evidence to support the effec-
tiveness of ORS. A fixed effect meta-analysis showed
a 69% (95% CI: 51–80%) pooled relative reduction in
diarrhoea mortality in communities in which ORS
was promoted compared with comparison areas,
with no indication of heterogeneity (Table 1). A
random effects meta-analysis similarly showed a
very low-pooled treatment failure rate (0.2%; 95%
CI: 0.1–0.2%) for ORS. Studies reporting treatment
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or clinic settings.
For the outcome of hospitalization/referral, 6 of 20
studies included a relevant comparison arm: five
quasi-experimental studies and one pre/post study.
Of the five quasi-experimental studies, two did not
clearly report the coverage achieved, one provided
regular home visits by nurses and a health education
component in the intervention but not comparison
arms and none discussed care-seeking practices in
intervention and control areas. The outcomes of
these studies were mixed, with two studies reporting
increases in hospitalization in the intervention relative
to the control area, whereas the other studies reported
47–57% relative decrease in hospitalization and
29–89% relative decreases in referrals to health
centres in the intervention areas.
We applied the CHERG Rules for Evidence Review
15
to the evidence presented in Table 1. We used the
pooled effect size for diarrhoea mortality, as it
was more conservative than the effect size for
severe morbidity (treatment failure). The mean and
median coverage levels in the intervention arms
of the diarrhoea mortality studies were 74%; assum-
ing a linear relationship between coverage and mor-
tality reduction, at 100% coverage a 93% relative
reduction in diarrhoea mortality would be expected
(Figure 2).
109 studies identified in 3 Cochrane reviews
166 studies obtained from 
subject area experts
PubMed, Cochrane Library and 
WHO Global Health Library
searches identifying 2122 studies 
205 papers identified for abstraction
404 papers reviewed for eligibility
2397 titles and abstracts screened for eligibility
Titles and abstracts screened
18 papers with 
data on ORT
184 papers with data
on ORS
23 papers with 
data on RHF
Papers abstracted
199 papers excluded because 
No relevant outcomes/insufficient data on outcomes (n=57);
Data not reported by age/treatment group (n=36);
Did not include the population of interest (n=30);
Review, comment, or treatment guideline (n=27);
Methods not sufficiently described (n=22);
Reported same data as other included papers (n=6); or
Did not use ORS/RHFs or co-interventions made it 
impossible to isolate effect of ORS/RHFs (n=5)
Figure 1 Search process for ORS and RHFs
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We identified and abstracted five studies reporting
diarrhoea mortality, one reporting all-cause mortality,
five reporting hospitalization or referral and 14 report-
ing treatment failure for RHFs (Supplementary
table 2). For the outcomes of diarrhoea and all-cause
mortality, no studies met the required study quality
criteria for inclusion in the meta-analyses.
We included 12 studies in the meta-analysis of
treatment failure and found a pooled failure rate of
0% (95% CI: 0.1 to 0.1%) (Table 2). However, each
of these studies included dehydrated patients and was
conducted in a hospital or clinic setting. Studies
assessed sugar solution and sugar- or cereal–salt solu-
tions; none assessed other RHFs such as plain water
or rice water. Due to the low quality of evidence
(i.e. no community-based studies) for serious morbid-
ity and the lack of well-designed studies assessing the
effect of RHFs on mortality, we did not estimate an
effect of RHFs on diarrhoea mortality (Figure 3).
ORT
We found 14 studies reporting diarrhoea mortality,
one reporting all-cause mortality and five reporting
dehydration or treatment failure for ORT that met
our inclusion/exclusion criteria (Supplementary
table 3). The studies abstracted are suggestive of an
effect of joint promotion of ORS and/or RHF on diar-
rhoea mortality. Of the studies reporting mortality
data with comparison groups (including historical
comparison groups), all reported a decline in diar-
rhoea or all-cause mortality, although the magnitude
of the declines, time periods over which they occurred
and the associated coverage levels varied greatly.
These studies primarily used pre/post designs and in
most cases did not adjust for confounding; thus, it is
not possible to determine whether the declines were
causally associated with the use of ORS and RHFs, or
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Treatment Failure (n=153; 1283 events)
ORS fails to improve or maintain hydration in 0.2% of 
treated episodes (0.1-0.2%)
Very low quality evidence for diarrhea mortality reduction and 
moderate quality evidence for improvement in serious morbidity:  
Plausible
Diarrhea Mortality (n=3; 68 events)
ORS reduces mortality by 69% (95% CI: 51-80%) 
given mean coverage of 74% (range 52-96%)
(93% reduction with 100% coverage)
Possible Outcome 
Measures
Application of 
Standard  Rulesa
Rules 1 & 2:  Do not apply
Very low quality evidence for cause-
specific mortality
Rule 3:  APPLY
Figure 2 Application of standardized rules for choice of
final outcome to estimate effect of ORS on the reduction
of diarrhoea mortality.
aSee Walker et al.
15 for a description
of the CHERG Rules for Evidence Review
i80 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYwith other interventions and changes occurring in the
community during the same time period.
Discussion
We found a large body of evidence evaluating the effi-
cacy and effectiveness of ORS, and a more limited
number of studies assessing RHFs. Based on this evi-
dence, we estimated that ORS may reduce diarrhoea
mortality by up to 93%, but were unable to estimate
the effectiveness of RHFs against diarrhoea mortality
because no studies were conducted outside hospital set-
ting, which is inconsistent with the definition of ‘home
fluids’ (Figures 2 and 3). Whereas the overall quality of
evidence supporting the effectiveness of ORS against
diarrhoea mortality was low as a result of non-
randomized study designs, our conclusions are
strengthened by the consistency of the effect size and
direction among the studies included and those
excluded from the meta-analysis. Moreover, the biolog-
ical basis for ORS, co-transport of glucose and sodium
across the epithelial layer in the small intestine is well
established and supports a protective effect of ORS
against fluid losses and electrolyte imbalances.
16,17
We correlated ORS effectiveness with coverage,
using the absolute coverage levels reported for the
intervention arms. However, in most community-
based studies, ORS was also available and used at a
low level in the comparison arms. The effective cov-
erage level (difference in coverage between the inter-
vention and comparison arms) was thus lower than
the absolute coverage level used in our calculations.
For this reason, our approach is conservative and
likely overestimates the coverage needed to achieve
a particular mortality reduction.
RHFs were not designed as an intervention to
directly decrease diarrhoea mortality, but were instead
intended to be used for home-based fluid manage-
ment to prevent dehydration, with possible indirect
effects on mortality. However, the only well-
controlled studies of RHFs were conducted in hospital
settings and included only sugar–salt solution and
cereal–salt solution. Whereas we included these stu-
dies in our meta-analysis of RHF treatment failure,
the results cannot be generalized to the administra-
tion of RHFs by a caregiver in the home and cannot
be assumed to be representative of all current RHFs.
Community-based studies of RHFs, which are not
only inherently less controlled but also more relevant
than hospital-based studies, have been conducted and
were abstracted into Supplementary table 2, but
either did not include a relevant comparison arm or
failed to adequately document the coverage achieved,
making it difficult to interpret their results. Moreover,
we were unable to find studies meeting our inclusion
criteria that assessed other RHFs such as water and
rice water. Thus, our findings may not be representa-
tive of the full range of RHFs.
ORS is a simple, proven intervention that can be
used at the community and facility level to prevent
and treat diarrhoeal dehydration and decrease diar-
rhoea mortality. Whereas ORS is highly effective, cov-
erage levels remain low in most countries. It is
essential that ORS coverage be increased to achieve
reductions in diarrhoea mortality; to do so, operations
and implementation research is needed to better
understand how to deliver ORS effectively and pro-
mote its use at home and facility level as part of
appropriate case management of diarrhoea.
In contrast to ORS, RHFs were designed and recom-
mended as a home-based intervention to prevent
diarrhoeal dehydration, but this message has
become confused as diarrhoea control programmes
have evolved. Moreover, for RHFs to be used appro-
priately at home, caregivers must be able to assess
whether a child is dehydrated and correctly determine
whether to provide RHFs or ORS. Thus, whereas there
is evidence suggesting that RHFs may be effective in
preventing dehydration, its correct implementation
and the associated behaviour change communication
messages are complex. From a programmatic perspec-
tive, promoting the use of ORS for all diarrhoea
episodes might, therefore, be both simpler and more
effective than promoting ORS and RHFs as a pack-
age and teaching caregivers when and how to use
each.
Supplementary data
Supplementary data are available at IJE online.
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Treatment Failure (n=12; 31 events)
RHFs fail to improve or maintain hydration in 
hospital/clinic settings in 0% of treated episodes
(−0.1 - 0.1%)
No evidence for mortality and referral and poor generalizability of the intervention for 
treatment failure: Insufficient data to estimate an effect of RHFs on mortality 
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15 for a description
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